基于慢性阻塞性肺疾病的比较疗效研究采取行动。 - Suppr

Suppr

超能文献

Acting on comparative effectiveness research in COPD.

作者信息

Krishnan Jerry A, Mularski Richard A

出版信息

JAMA. 2010 Jun 16;303(23):2409-10. doi: 10.1001/jama.2010.807.

DOI:10.1001/jama.2010.807

PMID:20551414

Abstract

摘要

相似文献

Acting on comparative effectiveness research in COPD.

JAMA. 2010 Jun 16;303(23):2409-10. doi: 10.1001/jama.2010.807.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD007033. doi: 10.1002/14651858.CD007033.pub3.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2011 Oct 5(10):CD007033. doi: 10.1002/14651858.CD007033.pub2.

ICS and COPD: time to clear the air.

Int J Chron Obstruct Pulmon Dis. 2009;4:289-90. doi: 10.2147/copd.s7143. Epub 2009 Aug 3.

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).

Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD012066. doi: 10.1002/14651858.CD012066.pub2.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD006829. doi: 10.1002/14651858.CD006829.pub2.

Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012355. doi: 10.1002/14651858.CD012355.pub2.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2013 Aug 30;2013(8):CD006826. doi: 10.1002/14651858.CD006826.pub2.

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

Eur Respir J. 2014 Apr;43(4):1201-3. doi: 10.1183/09031936.00162313. Epub 2013 Oct 31.

Comparative Effectiveness of Long-Acting Beta -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.

Pharmacotherapy. 2017 Apr;37(4):447-455. doi: 10.1002/phar.1913.

引用本文的文献

Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model.

Evid Based Complement Alternat Med. 2019 Apr 17;2019:6478926. doi: 10.1155/2019/6478926. eCollection 2019.

Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and Pitfalls.

Paediatr Drugs. 2018 Feb;20(1):1-7. doi: 10.1007/s40272-017-0256-y.

Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial.

Trials. 2014 May 1;15:153. doi: 10.1186/1745-6215-15-153.

Designing and evaluating a clustering system for organizing and integrating patient drug outcomes in personal health messages.

AMIA Annu Symp Proc. 2012;2012:417-26. Epub 2012 Nov 3.

Comparative effectiveness research in chronic obstructive pulmonary disease.

J Comp Eff Res. 2012 Jan;1(1):71-82. doi: 10.2217/cer.11.10.

A new taxonomy for stakeholder engagement in patient-centered outcomes research.

J Gen Intern Med. 2012 Aug;27(8):985-91. doi: 10.1007/s11606-012-2037-1. Epub 2012 Apr 13.

The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.

Chest. 2012 Jan;141(1):87-93. doi: 10.1378/chest.11-0024. Epub 2011 Jul 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验